文献速递心脏核医学

缺血引导与常规非罪犯血管成形术治疗ST段抬高型心肌梗死合并多支血管病变患者:国际原子能机构SPECT STEMI试验

Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial.
PubMed 文献 · J Nucl Cardiol · 2022-10-25

该国际随机非劣效试验纳入9个国家109例STEMI合并多支血管病变患者,比较直接PCI后缺血引导与常规非罪犯血管成形术。随访应激MPI显示两组缺血心肌百分比中位数均为2.9%,差异0.13%(95%CI -1.3%-1.6%,P<.0001,非劣效界值5%),缺血引导策略非劣于常规策略。

要点

  • 缺血引导组48例中25例(47%)在应激MPI后接受非罪犯血管PCI。
  • 常规组56例中43例(77%)接受非罪犯血管成形术,其中86%在随机化6周内完成。
  • 随访影像(平均16.5个月)缺血心肌百分比中位数两组均为2.9%,差异0.13%(95%CI -1.3%-1.6%)。

核心结论

  • 缺血引导的非罪犯血管PCI策略使缺血负荷低,在降低缺血负荷方面非劣于常规非罪犯血管PCI策略。
  • STEMI后选择性非罪犯血管PCI具有节省费用的潜力,可能尤其适用于资源匮乏环境。

研究设计与样本

  • 国际、随机、非劣效试验,比较STEMI直接PCI后缺血引导与常规非罪犯血管成形术。
  • 共纳入来自9个国家的109例患者。
  • 主要结局为随访应激MPI缺血心肌百分比的组间差异,所有MPI图像在核心实验室集中处理分析,对治疗分配设盲。

主要发现

  • 缺血引导组48例中25例(47%)在应激MPI后接受非罪犯血管PCI。
  • 常规非罪犯血管PCI组56例中43例(77%)接受血管成形术,其中86%在随机化6周内完成。
  • 随访影像(平均16.5个月)缺血心肌百分比中位数低,两组均为2.9%,差异0.13%(95%CI -1.3%-1.6%,P<.0001;非劣效界值5%)。

关键数值与推荐

  • 非劣效界值为5%。
  • 主要结局组间差异0.13%(95%CI -1.3%-1.6%,P<.0001)。
  • 随访影像平均16.5个月,缺血心肌百分比中位数两组均为2.9%。

临床怎么用

  • STEMI直接PCI后采用缺血引导的非罪犯血管PCI策略可使缺血负荷低,且非劣于常规非罪犯血管PCI策略。
  • 作者认为STEMI后选择性非罪犯血管PCI具有节省费用的潜力,可能尤其适用于资源匮乏环境。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with multi-vessel disease presenting with ST elevation myocardial infarction (STEMI), the efficacy and safety of ischemia-guided, vs routine non-culprit vessel angioplasty has not been adequately studied. METHODS: We conducted an international, randomized, non-inferiority trial comparing ischemia-guided non-culprit vessel angioplasty to routine non-culprit vessel angioplasty, following primary PCI for STEMI. The primary outcome was the between-group difference in percent ischemic myocardium at follow-up stress MPI. All MPI images were processed and analyzed at a central core lab, blinded to treatment allocation. RESULTS: In all, 109 patients were enrolled from nine countries. In the ischemia-guided arm, 25/48 (47%) patients underwent non-culprit vessel PCI following stress MPI. In the routine non-culprit PCI arm, 43/56 (77%) patients underwent angioplasty (86% within 6 weeks of randomization). The median percentage of ischemic myocardium on follow-up imaging (mean 16.5 months) was low, and identical (2.9%) in both arms (difference 0.13%, 95%CI - 1.3%-1.6%, P < .0001; non-inferiority margin 5%). CONCLUSION: A strategy of ischemia-guided non-culprit PCI resulted in low ischemia burden, and was non-inferior to a strategy of routine non-culprit vessel PCI in reducing ischemia burden. Selective non-culprit PCI following STEMI offers the potential for cost-savings, and may be particularly relevant to low-resource settings. (CTRI/2018/08/015384).

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Karthikeyan G, Peix A, Devasenapathy N, et al. Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial. J Nucl Cardiol. 2022. PMID: 36284033. doi:10.1007/s12350-022-03108-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。